Nektar (NKTR) Comments on Pfizer's Exubera Roll Out, Raises Exubera Sales Guidance
Tweet Send to a Friend
Nektar Therapeutics (Nasdaq: NKTR) reported that Pfizer Inc (NYSE: PFE) announced that it will introduce Exubera Inhalation Powder in the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


